Search

Your search keyword '"Lewis, Mark"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Lewis, Mark" Remove constraint Author: "Lewis, Mark" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
226 results on '"Lewis, Mark"'

Search Results

4. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia

6. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques

7. Provision of Interventional Radiology Services 2023

9. Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

10. Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC

12. Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques

13. Sources of informal financial support among adolescent and young adult cancer survivors: a mixed methods analysis from the HIAYA CHAT study

15. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

18. HIAYA CHAT study protocol: a randomized controlled trial of a health insurance education intervention for newly diagnosed adolescent and young adult cancer patients

20. Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques

21. Deep ocean drivers better explain habitat preferences of sperm whales Physeter macrocephalus than beaked whales in the Bay of Biscay

22. Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques

26. “I thought there would be more I understood”: health insurance literacy among adolescent and young adult cancer survivors

28. Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates

29. Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters

30. Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2

32. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine

33. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

34. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge

35. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

36. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

37. Accurate long-range forecasting of COVID-19 mortality in the USA

38. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques

39. A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells

40. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19

42. Correlates of protection against SARS-CoV-2 in rhesus macaques

43. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

44. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

47. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

49. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques

Catalog

Books, media, physical & digital resources